0001209191-17-031937.txt : 20170512
0001209191-17-031937.hdr.sgml : 20170512
20170512162032
ACCESSION NUMBER: 0001209191-17-031937
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Fred E
CENTRAL INDEX KEY: 0001339358
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 17838921
MAIL ADDRESS:
STREET 1: 301 COMMERCE STREET
STREET 2: SUITE 3300
CITY: FORT WORTH
STATE: TX
ZIP: 76102
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-10
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001339358
Cohen Fred E
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
29.80
2017-05-10
4
A
0
10000
0.00
A
2027-05-09
Common Stock
10000
10000
D
This option will vest in its entirety on the earlier to occur of (i) May 10, 2018 or (ii) the day before the 2018 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.
/s/ Francis Sarena, Attorney-in-fact
2017-05-12